Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHP in SIRS Patients With Shock
NCT00021502Phase 3Completed
- Sponsor
- Apex Bioscience
- Start
- Mar 2001
- Primary completion
- Aug 2003
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in Systemic Inflammatory Response Syndrome (SIRS) and Shock comparing PHP + Vasopressors with Placebo + Vasopressors (2 arms). Started Mar 2001; status: completed.
02
Drugs
hemoximer
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)Shock
Beyond the preview
Go deeper on NCT00021502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021502.